VANCOUVER, March 14, 2018 /CNW/ - INVICTUS MD STRATEGIES
CORP. ("Invictus" or the "Company") (TSXV: IMH; OTC: IVITF; FRA:
8IS1) announced today that rock 'n' roll legend and marketing
and branding innovator Gene Simmons,
co-founder of KISS: America's #1 Gold Record Award Winning
Group of all time, has joined Invictus as Chief Evangelist
Officer.
The partnership involves Simmons' leadership in a variety of
capacities focused on assisting the Company with its public
awareness strategy and eventual branding strategy for the
recreational market that is anticipated to be legal in
Canada in 2018. His
responsibilities will include providing marketing counsel, serving
as a spokesperson in the media, public appearances and
participation in the Company's annual general meeting and investor
meetings, among others.
"Gene Simmons is a branding and
merchandising genius, who not only created one of the most iconic
bands of all time, but has spent decades building successful brands
internationally in various industries," said Dan Kriznic, Chairman
and CEO of Invictus. "Gene will lead marketing initiatives that
will help spread the positive messages that dwell at the heart of
Invictus in accordance with the strict
regulations of Health Canada's Access to Cannabis for
Medical Purposes Regulations (ACMPR), the Food and Drugs
Act (FDA) and the Narcotic Control Regulations (NCR)" said
Kriznic.
"Values and family are very important to me, and when I first
connected with Dan at Invictus, I understood immediately that we
enjoyed a shared passion for these key life foundations," said
Gene. "Instead of launching straight into business, we talked about
the things that matter the most."
While Simmons has achieved extraordinary success beyond the
concert stage and recording studio, his KISS-related achievements
are astounding in themselves with the band having sold more than
100 million albums; earning more American Gold Record Awards than
any other group, in all categories (RIAA); building a
merchandising/licensing empire with over 2,500 licenses including
everything from t-shirts and comic books, to pinball machines,
credit cards and lunchboxes; and breaking box office records set by
The Beatles and Elvis.
Beyond KISS, Simmons' celebrity television show, Gene Simmons
Family Jewels, aired for eight years and 167 episodes, and
was viewed in 84 countries — one of the longest-running
celebrity reality TV shows in history. He discovered Van Halen, managed the recording career of
Liza Minnelli, and is a founding
partner in the global restaurant chain Rock & Brews.
Simmons' achievements in marketing encouraged McClaren to hire
him as their brand ambassador and Indycar engaged him to do their
marketing. Simmons has a record label Simmons Records, is a published author with
Simmons Books about to publish
his latest book "27", on the heels of his two previous best sellers
Me, Inc., and On Power; and Simmons Comics continues to grow. In
addition, he published his own magazine, Tongue (Sterling-McFadden)
and is about to launch his newest magazine, "iMOGU" focusing on
entrepreneurs that matter. Simmons created and executive produced
the TV shows My Dad The Rock Star, Mr. Romance, and others. He has
also acted in numerous motion pictures and television shows for
more than three decades and is currently co-producing a slate of
motion pictures with Arclight Films.
Simmons is a partner in the New York-based Family Office of
Highmore Group Advisors, he has rang the bell at the New York Stock
Exchange and the Toronto Stock Exchange, and was keynote
speaker at NASDAQ. Gene Simmons also had a United States
Postage Stamp.
Among his latest ventures, Simmons is launching a premium soda
line, MoneyBag™ Sodas, across all 7-Eleven stores; his 50th
anniversary rock tour, Gene Simmons:
The Vault Experience, continues with stops around the world; and,
he will soon launch MoneyBag™ FootGear.
Terms of the agreement
Pursuant to the terms of the agreement Invictus acquired all the
issued and outstanding shares of Gene-Etics Strains Co.
from Gene Simmons and Simmons will provide the marketing and
branding efforts described above for a purchase price
comprising of $2.5-million (U.S.)
payable in cash and the issuance of 2,631,141 common shares in the
capital of Invictus to be paid on the closing date. Invictus
and Simmons will also enter into a management services agreement
and international licensing agreement, for an additional 1,973,355
common shares and a second tranche of 1,973,355 common shares to be
issued to Simmons on the later of 240 days following the closing
date and January 2, 2019.
The shares are being issued at a deemed price of $1.97
About Invictus MD Strategies Corp.
Invictus MD Strategies Corp. is focused on two main verticals
within the Canadian cannabis sector, namely the Licensed
Producers under the ACMPR, being its 100% investment in Acreage
Pharms Ltd., located in West-Central Alberta, and 50% investment in
AB Laboratories Inc., located near Hamilton, Ontario, that has its cultivation
and sales license under ACMPR. In addition to ACMPR licenses, the
Company has an 82.5% investment in Future Harvest Development Ltd.
a Fertilizer and Nutrients manufacturer based in Kelowna, British Columbia.
For more information, please visit www.invictus-md.com.
On Behalf of the Board,
Dan Kriznic
Chairman & CEO
Larry Heinzlmeir
Vice President, Marketing & Communications
604-537-8676
In the United States
Terry Wills
310-877-1458
Cautionary Note Regarding Forward-Looking Statements: This
release includes certain statements and information that may
constitute forward-looking information within the meaning of
applicable Canadian securities laws or forward-looking statements
within the meaning of the United States Private Securities
Litigation Reform Act of 1995. All statements in this news release,
other than statements of historical facts, including statements
regarding future estimates, plans, objectives, timing, assumptions
or expectations of future performance, including Invictus'
successful negotiation and signing of the international licensing
agreement and the management services agreement with Gene, the
issuance of the second and third tranche of the Company's common
shares to Gene and the legalization of the recreational use of
marijuana in Canada in 2018 are
forward-looking statements and contain forward-looking information.
Generally, forward-looking statements and information can be
identified by the use of forward-looking terminology such as
"intends" or "anticipates", or variations of such words and phrases
or statements that certain actions, events or results "may",
"could", "should", "would" or "occur". Forward-looking statements
are based on certain material assumptions and analysis made by the
Company and the opinions and estimates of management as of the date
of this press release, including Invictus' successful negotiation
and signing of the international licensing agreement and the
management services agreement with Gene, the issuance of the second
and third tranche of the Company's common shares to Gene and the
legalization of recreational use of cannabis in Canada will occur in 2018. These
forward-looking statements are subject to known and unknown risks,
uncertainties and other factors that may cause the actual results,
level of activity, performance or achievements of the Company to be
materially different from those expressed or implied by such
forward-looking statements or forward-looking information.
Important factors that may cause actual results to vary, include,
without limitation, Invictus will not successfully negotiate and
sign the international licensing agreement and the management
services agreement with Gene, Invictus will not issue the second
and third tranche of the Company's common shares to Gene and the
legalization of the recreational use of marijuana in Canada will not occur at all or as expected.
Although management of the Company has attempted to identify
important factors that could cause actual results to differ
materially from those contained in forward-looking statements or
forward-looking information, there may be other factors that cause
results not to be as anticipated, estimated or intended. There can
be no assurance that such statements will prove to be accurate, as
actual results and future events could differ materially from those
anticipated in such statements. Accordingly, readers should not
place undue reliance on forward-looking statements and
forward-looking information. Readers are cautioned that reliance on
such information may not be appropriate for other purposes. The
Company does not undertake to update any forward-looking statement,
forward-looking information or financial out-look that are
incorporated by reference herein, except in accordance with
applicable securities laws. We seek safe harbor.
Neither the TSX Venture Exchange nor its Regulation Services
Provider (as that term is defined in the policies of the TSX
Venture Exchange) accepts responsibility for the adequacy or
accuracy of this release.
SOURCE Invictus MD Strategies